Patent · US Active

Method for validating a medical application, end user device and medical system

US11620212B2 · kind B2 · utility

0Cited by

3References

11Claims

0Family size

Assignee

Roche Diabetes Care, Inc. · US

Inventors

Kai-Oliver Schwenker · Haßloch, DE
Thomas Eissenloeffel · Heidelberg, DE
Bimal Thayyil · Mannheim, DE

Key dates

Filing date	Mar 19, 2020
Grant date	Apr 4, 2023
Priority date	—
Expiry date	Feb 16, 2041

Classification

Technology area (CPC H)Electricity
CPC primaryH04L2209/88
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

An inventive method for validating an end user device for use with a medical application. A medical application and a validation application are received in the end user device and the validation application is then executed, which includes: (i) determining the hardware and software environment of the end user device; (ii) providing a validation process compatible with the hardware and software environment; (iii) executing a test mode of the medical application; (iv) running the validation process during the test mode; and (v) determining from running the validation process whether the medical application is compatible with the end user device. When the medical application is determined to be compatible with the end user device, a validation report is generated and stored in the end user device and/or a server. When the medical application is determined to be incompatible with the end user device, the medical application is at least partially blocked.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.